Introduction: For over 20 years, U.S. active sunscreen ingredients have been limited, unlike the fast-developing global sunscreen technology. In late 2025, the U.S. FDA proposed approving Bemotrizinol, a broad-spectrum UV filter widely used in Europe and Asia, as a new active sunscreen ingredient—its first major list expansion since the late 1990s. This article analyzes the shift from three aspects: slow ingredient updates, Bemotrizinol’s core features, and its implications for consumers.

Why U.S. Sunscreen Ingredients Update Slowly

U.S. sunscreen is regulated as an OTC drug, not a cosmetic. New active ingredients require extensive safety and efficacy data for strict certification, leading to long, costly approval. Thus, U.S. consumers have far fewer UV filters than Europe and Asia. As skin cancer is the U.S.’s most common cancer, the FDA faces pressure to upgrade standards while ensuring safety—driving this new ingredient proposal.

What Bemotrizinol Is — and What It Isn’t

Bemotrizinol, the FDA’s proposed core ingredient, is a widely used broad-spectrum UV filter. Clarify its features and misconceptions:

1. Core Advantages: Blocks UVA/UVB rays, has strong photostability, and extremely low skin absorption, with proven safety data.
2. Common Misconceptions: It is still under FDA’s final review, not yet approved. Even if approved, it does not outperform existing ingredients—only adds an FDA-compliant formulation option.

What Bemotrizinol Approval Means for U.S. Consumers

If approved, Bemotrizinol will be the U.S.’s first new core sunscreen ingredient in nearly 30 years, with practical value but limited short-term impact:

1. Product Upgrades: It enables lighter, more refreshing, longer-wearing sunscreens, encouraging daily sun protection.
2. Unchanged Principles: Public health still recommends SPF 30+ broad-spectrum sunscreens; this ingredient only expands options.
3. Short-Term Status: The FDA’s proposal is not final—no immediate market changes; consumers can use existing compliant products.

Overall, Bemotrizinol’s approval progress upgrades the U.S. sunscreen system and aligns it with international standards, paving the way for more globally verified, safe, effective sunscreen ingredients.